Hosted on MSN1mon
Zentalis pharmaceuticals director Luke Walker buys $24,966 in stockZentalis Pharmaceuticals, based in San Diego, focuses on the development of small molecule therapeutics targeting cancer. According to InvestingPro data, the company maintains a strong liquidity ...
SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ...
SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback